I

Institut Jantung Negara | Clinical Research Department

Research site
(Unclaimed)
Location
145 Jalan Tun Razak, Kuala Lumpur, Selangor, Malaysia
Site insights

Top conditions

Coronary Artery Disease (8 trials)

Coronary Disease (7 trials)

Myocardial Ischemia (7 trials)

Atrial Fibrillation (5 trials)

Heart Failure (4 trials)

Top treatments

Macitentan
JNJ-67896049
Thienopyridine
Rocuronium
Medication
dabigatran
Pradaxa
Nitric Oxide
Cis-atracurium
Vitamin K

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 35
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH) (TOMORROW)

This is a prospective, multicenter, open-label, randomized, controlled, parallel Phase 3 study with an open-label single-arm extension period to eval...

Enrolling
Pulmonary Arterial Hypertension
Drug: Macitentan
Other: Standard-of-care

BIOFLOW-DAPT is a prospective, multi-center, international, two-arm randomized controlled clinical study.A total of 1'948 subjects will be randomized...

Active, not recruiting
Coronary Artery Disease
Device: Percutaneous coronary intervention

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safety of Abl...

Active, not recruiting
Coronary Artery Disease
Diabetes
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)

Trial sponsors

Boston Scientific logo

Boston Scientific (11 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems